Artemether
Back to searchMolecule Structure
Scientific Name
Artemether
Description of the Drug
Artemether is an antimalarial agent used in combination with lumefantrine for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06697
http://www.drugbank.ca/drugs/DB06697
Brand Name(s)
Artemetheri
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ferriprotoporphyrin IX | SMALL MOLECULE | INHIBITOR | CHEMBL613897 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1650501 |
| Human Metabolome Database | HMDB0015643 |
| DrugBank | DB06697 |
| PubChem: Thomson Pharma | 15345648 |
| PubChem | 68911 |
| Mcule | MCULE-9916057476 |
| LINCS | LSM-5519 |
| Nikkaji | J41.424G |
| PDBe | D8Z |
| BindingDB | 50248200 |
| EPA CompTox Dashboard | DTXSID7040651 |
| DrugCentral | 245 |
| Brenda | 232699 |
| Guide to Pharmacology | 9955 |
| rxnorm | ARTEMETHER |
| PubChem: Drugs of the Future | 12013078 |
| ChEBI | 195280 |
| ZINC | ZINC000014263142 |
